&nbsp;

Jul 2014

Drug

fulvestrant

Other Name(s): Faslodex®

Quick Link(s):

Jan 2024

Drug

letrozole

Other Name(s): Femara®

Quick Link(s):

Nov 2020

Drug

leucovorin

Other Name(s): Lederle Leucovorin® (multiple brands available)

Quick Link(s):

Dec 1969

Drug

lomustine

Other Name(s): CeeNU®

Quick Link(s):

Dec 1969

Drug

lanreotide

Other Name(s): Somatuline® Autogel®

Quick Link(s):

Dec 1969

Regimen

LETR

Cancer Type:

Breast

Intent: Adjuvant

Funding:

ODB - General Benefit

letrozole

Drugs Used:

letrozole

Quick Link(s):

Regimen Monograph

Nov 2020

Regimen

LETR

Cancer Type:

Breast

Intent: Palliative

Funding:

ODB - General Benefit

letrozole

Drugs Used:

letrozole

Quick Link(s):

Regimen Monograph

Nov 2020

Regimen

LOMU

Cancer Type:

Central Nervous System

Intent: Palliative

Funding:

ODB - General Benefit

lomustine

Drugs Used:

lomustine

Quick Link(s):

Regimen Monograph

Regimen

FLVS

Cancer Type:

Breast

Intent: Palliative

Funding:

ODB - General Benefit

fulvestrant

Drugs Used:

fulvestrant

Quick Link(s):

Regimen Monograph

Regimen

FLTM

Cancer Type:

Genitourinary,

Prostate

Intent: Palliative

Funding:

ODB - General Benefit

flutamide

Drugs Used:

flutamide

Quick Link(s):

Regimen Monograph

Oct 2016

Regimen

FC(PO)+R

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

ODB - General Benefit

cyclophosphamide - oral tablets

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC in Combination with Chemotherapy - Indolent B-cell Lymphoma

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Indolent Lymphoma

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC in Combination with Chemotherapy - Indolent B-cell Lymphoma

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Indolent Lymphoma

Drugs Used:

riTUXimab,

fludarabine (Unfunded),

cyclophosphamide,

riTUXimab (subcut)